Alkermes terminates authorized generic VIVITROL supply agreement with Amneal

Alkermes plc.

Agreement dated Sept 9, 2025, for Amneal to distribute authorized generic VIVITROL in the US.
Terminated July 6, 2026, after Amneal failed to meet certain terms and declined to order batches.
No penalties incurred; both parties released all claims related to the agreement.
No further payments or obligations owed by either party under the terminated agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.